These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25195168)

  • 21. Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5alpha (TRIM 5alpha) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue.
    Anderson J; Akkina R
    Hum Gene Ther; 2008 Mar; 19(3):217-28. PubMed ID: 18279037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.
    Berthoux L; Sebastian S; Sokolskaja E; Luban J
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14849-53. PubMed ID: 16203999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparate Contributions of Human Retrovirus Capsid Subdomains to Gag-Gag Oligomerization, Virus Morphology, and Particle Biogenesis.
    Martin JL; Mendonça LM; Angert I; Mueller JD; Zhang W; Mansky LM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No effect of endogenous TRIM5alpha on HIV-1 production.
    Zhang F; Perez-Caballero D; Hatziioannou T; Bieniasz PD
    Nat Med; 2008 Mar; 14(3):235-6; author reply 236-8. PubMed ID: 18323834
    [No Abstract]   [Full Text] [Related]  

  • 25. Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha.
    Campbell EM; Perez O; Anderson JL; Hope TJ
    J Cell Biol; 2008 Feb; 180(3):549-61. PubMed ID: 18250195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro.
    Black LR; Aiken C
    J Virol; 2010 Jul; 84(13):6564-9. PubMed ID: 20410272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-amino acid mutation 66SR in Gag-matrix enhances viral single-cycle infectivity of R5-tropic HIV-1rmt.
    Doi N; Sakai Y; Miyazaki Y; Adachi A; Nomaguchi M
    J Med Invest; 2015; 62(3-4):228-32. PubMed ID: 26399353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.
    Imam S; Kömürlü S; Mattick J; Selyutina A; Talley S; Eddins A; Diaz-Griffero F; Campbell EM
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIM5α and Species Tropism of HIV/SIV.
    Nakayama EE; Shioda T
    Front Microbiol; 2012; 3():13. PubMed ID: 22291694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
    Yap MW; Nisole S; Lynch C; Stoye JP
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10786-91. PubMed ID: 15249690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The conserved sumoylation consensus site in TRIM5α modulates its immune activation functions.
    Nepveu-Traversy MÉ; Berthoux L
    Virus Res; 2014 May; 184():30-8. PubMed ID: 24583231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells.
    Bérubé J; Bouchard A; Berthoux L
    Retrovirology; 2007 Sep; 4():68. PubMed ID: 17892575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and characterization of a stable full-length ecotropic murine leukemia virus molecular clone that produces novel phenotypes to Fv1 restriction.
    Bae EH; Park SH; Park SM; Park JW; Lim MS; Jung YT
    J Microbiol Biotechnol; 2008 Apr; 18(4):799-804. PubMed ID: 18467880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel TRIM5 isoforms expressed by Macaca nemestrina.
    Brennan G; Kozyrev Y; Kodama T; Hu SL
    J Virol; 2007 Nov; 81(22):12210-7. PubMed ID: 17804491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic regulation of HIV-1 capsid interaction with the restriction factor TRIM5α identified by magic-angle spinning NMR and molecular dynamics simulations.
    Quinn CM; Wang M; Fritz MP; Runge B; Ahn J; Xu C; Perilla JR; Gronenborn AM; Polenova T
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11519-11524. PubMed ID: 30333189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of human TRIM5alpha on HIV-1 production.
    Zhang X; Kondo M; Chen J; Miyoshi H; Suzuki H; Ohashi T; Shida H
    Microbes Infect; 2010 Sep; 12(10):768-77. PubMed ID: 20493962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of simian-tropic HIV-1 by restriction factor evasion.
    Hatziioannou T; Princiotta M; Piatak M; Yuan F; Zhang F; Lifson JD; Bieniasz PD
    Science; 2006 Oct; 314(5796):95. PubMed ID: 17023652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptation of HIV-1 to cells expressing rhesus monkey TRIM5α.
    Pacheco B; Finzi A; Stremlau M; Sodroski J
    Virology; 2010 Dec; 408(2):204-12. PubMed ID: 20956011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus.
    Maegawa H; Miyamoto T; Sakuragi J; Shioda T; Nakayama EE
    Virology; 2010 Apr; 399(2):212-20. PubMed ID: 20110098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity.
    Battivelli E; Migraine J; Lecossier D; Yeni P; Clavel F; Hance AJ
    J Virol; 2011 Nov; 85(22):11846-54. PubMed ID: 21917976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.